CBLN1 and ovarian carcinoma: In our previous study it was revealed that the alterations in serum ceramides, i.e., their increase or decrease, is dependent on the fatty acyl side chain, and Cer(d18:1/18:0) showed the strongest elevation due to ovarian cancer [15].